Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spondylosis | 2 | 2017 | 81 | 1.100 |
Why?
|
Oropharyngeal Neoplasms | 2 | 2019 | 477 | 0.950 |
Why?
|
Spinal Cord Diseases | 2 | 2017 | 298 | 0.930 |
Why?
|
Head and Neck Neoplasms | 6 | 2019 | 2736 | 0.920 |
Why?
|
Aerosols | 3 | 2021 | 623 | 0.920 |
Why?
|
Spinal Cord Neoplasms | 2 | 2016 | 281 | 0.910 |
Why?
|
Cervical Vertebrae | 3 | 2017 | 976 | 0.820 |
Why?
|
Medicare | 9 | 2023 | 6565 | 0.810 |
Why?
|
Medicare Part B | 1 | 2022 | 108 | 0.780 |
Why?
|
Reimbursement, Incentive | 3 | 2021 | 540 | 0.770 |
Why?
|
Carcinoma, Squamous Cell | 5 | 2019 | 4033 | 0.730 |
Why?
|
Hypoglossal Nerve | 2 | 2022 | 95 | 0.720 |
Why?
|
Otolaryngology | 4 | 2020 | 643 | 0.700 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2019 | 63 | 0.680 |
Why?
|
Spinal Fractures | 2 | 2015 | 696 | 0.660 |
Why?
|
Financial Management | 1 | 2020 | 160 | 0.660 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 5 | 2020 | 312 | 0.660 |
Why?
|
Cochlear Implantation | 1 | 2023 | 310 | 0.650 |
Why?
|
Hospital Charges | 1 | 2020 | 362 | 0.640 |
Why?
|
Alopecia | 1 | 2022 | 382 | 0.640 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2019 | 215 | 0.640 |
Why?
|
Cochlear Implants | 1 | 2023 | 339 | 0.630 |
Why?
|
Electric Stimulation Therapy | 2 | 2022 | 605 | 0.610 |
Why?
|
Neck Dissection | 1 | 2019 | 197 | 0.600 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2019 | 234 | 0.590 |
Why?
|
Outsourced Services | 1 | 2016 | 21 | 0.580 |
Why?
|
Neurosurgical Procedures | 3 | 2018 | 2002 | 0.570 |
Why?
|
Tracheostomy | 1 | 2020 | 401 | 0.560 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2019 | 252 | 0.560 |
Why?
|
Surgery, Plastic | 1 | 2023 | 624 | 0.560 |
Why?
|
Morpholines | 1 | 2019 | 571 | 0.540 |
Why?
|
Quality of Life | 8 | 2022 | 12788 | 0.530 |
Why?
|
Specialties, Surgical | 1 | 2020 | 391 | 0.530 |
Why?
|
Thoracic Vertebrae | 2 | 2017 | 608 | 0.520 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 546 | 0.490 |
Why?
|
Disclosure | 1 | 2020 | 737 | 0.490 |
Why?
|
Decompression, Surgical | 2 | 2016 | 594 | 0.490 |
Why?
|
Lumbar Vertebrae | 3 | 2017 | 1848 | 0.460 |
Why?
|
Endoscopy | 3 | 2020 | 1781 | 0.450 |
Why?
|
Thrombospondins | 3 | 2020 | 200 | 0.440 |
Why?
|
Parkinson Disease | 2 | 2017 | 2785 | 0.440 |
Why?
|
Pyrroles | 1 | 2019 | 1147 | 0.430 |
Why?
|
Health Care Costs | 3 | 2023 | 3207 | 0.420 |
Why?
|
Medicine | 1 | 2020 | 945 | 0.410 |
Why?
|
Motivation | 2 | 2021 | 1971 | 0.400 |
Why?
|
Home Care Services | 1 | 2017 | 608 | 0.390 |
Why?
|
Astrocytoma | 1 | 2016 | 790 | 0.390 |
Why?
|
Spinal Fusion | 2 | 2017 | 1241 | 0.380 |
Why?
|
Sleep Apnea, Obstructive | 2 | 2022 | 1813 | 0.370 |
Why?
|
Cross-Sectional Studies | 13 | 2023 | 25032 | 0.360 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2568 | 0.340 |
Why?
|
Facial Paralysis | 2 | 2023 | 338 | 0.340 |
Why?
|
Costs and Cost Analysis | 3 | 2023 | 1680 | 0.330 |
Why?
|
Piperazines | 1 | 2019 | 2487 | 0.330 |
Why?
|
Surgery, Computer-Assisted | 1 | 2017 | 1017 | 0.330 |
Why?
|
Retrospective Studies | 26 | 2023 | 77410 | 0.320 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3134 | 0.310 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3241 | 0.310 |
Why?
|
Lymph Nodes | 1 | 2019 | 3476 | 0.310 |
Why?
|
Papillomavirus Infections | 1 | 2019 | 1587 | 0.310 |
Why?
|
Multiple Myeloma | 2 | 2015 | 5185 | 0.300 |
Why?
|
Telemedicine | 2 | 2022 | 2874 | 0.300 |
Why?
|
United States | 18 | 2023 | 69859 | 0.290 |
Why?
|
Humans | 64 | 2023 | 743811 | 0.290 |
Why?
|
Databases, Factual | 2 | 2019 | 7729 | 0.270 |
Why?
|
Ossification, Heterotopic | 2 | 2018 | 239 | 0.260 |
Why?
|
Patient Acceptance of Health Care | 1 | 2017 | 3020 | 0.230 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4033 | 0.230 |
Why?
|
Insurance, Health | 3 | 2022 | 2492 | 0.230 |
Why?
|
Biological Products | 2 | 2022 | 859 | 0.220 |
Why?
|
Middle Aged | 24 | 2020 | 213241 | 0.210 |
Why?
|
Relative Value Scales | 2 | 2020 | 84 | 0.210 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6539 | 0.210 |
Why?
|
Facial Nerve Injuries | 1 | 2022 | 63 | 0.210 |
Why?
|
Physicians | 1 | 2020 | 4569 | 0.210 |
Why?
|
Cisplatin | 2 | 2019 | 1662 | 0.210 |
Why?
|
Hospitals | 4 | 2023 | 3953 | 0.200 |
Why?
|
Voice Quality | 2 | 2020 | 217 | 0.200 |
Why?
|
Lymphatic Metastasis | 2 | 2019 | 2924 | 0.190 |
Why?
|
Adenoidectomy | 1 | 2022 | 159 | 0.190 |
Why?
|
Aged | 19 | 2023 | 163178 | 0.190 |
Why?
|
Hypersensitivity | 2 | 2021 | 1102 | 0.190 |
Why?
|
Male | 29 | 2022 | 349776 | 0.190 |
Why?
|
Voice Training | 1 | 2020 | 38 | 0.190 |
Why?
|
Negotiating | 1 | 2022 | 133 | 0.190 |
Why?
|
Female | 31 | 2022 | 380020 | 0.190 |
Why?
|
Legislation as Topic | 1 | 2020 | 80 | 0.180 |
Why?
|
Olfactory Mucosa | 1 | 2021 | 98 | 0.180 |
Why?
|
Leuprolide | 1 | 2022 | 321 | 0.180 |
Why?
|
Compensation and Redress | 1 | 2020 | 71 | 0.180 |
Why?
|
Cautery | 1 | 2020 | 72 | 0.180 |
Why?
|
Survival Rate | 3 | 2019 | 12786 | 0.180 |
Why?
|
Fee Schedules | 1 | 2020 | 86 | 0.180 |
Why?
|
T-Lymphocytes | 2 | 2017 | 10179 | 0.180 |
Why?
|
Neoplasm Staging | 3 | 2019 | 11036 | 0.180 |
Why?
|
Otorhinolaryngologic Diseases | 1 | 2020 | 90 | 0.180 |
Why?
|
Anti-Anxiety Agents | 1 | 2022 | 390 | 0.170 |
Why?
|
Baculoviridae | 1 | 2019 | 118 | 0.170 |
Why?
|
Radiation Injuries | 2 | 2017 | 1180 | 0.170 |
Why?
|
Suction | 1 | 2020 | 267 | 0.170 |
Why?
|
Hair | 1 | 2022 | 480 | 0.170 |
Why?
|
Caspase 8 | 1 | 2019 | 195 | 0.170 |
Why?
|
Marketing of Health Services | 1 | 2020 | 153 | 0.170 |
Why?
|
Antineoplastic Agents | 2 | 2019 | 13691 | 0.170 |
Why?
|
Cordotomy | 1 | 2018 | 8 | 0.160 |
Why?
|
Rhinoplasty | 1 | 2022 | 226 | 0.160 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2019 | 197 | 0.160 |
Why?
|
Dysphonia | 1 | 2020 | 144 | 0.160 |
Why?
|
Treatment Outcome | 9 | 2019 | 63042 | 0.150 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2020 | 520 | 0.150 |
Why?
|
Paranasal Sinuses | 1 | 2020 | 250 | 0.150 |
Why?
|
Nasopharynx | 1 | 2020 | 379 | 0.150 |
Why?
|
Cost Control | 1 | 2020 | 624 | 0.150 |
Why?
|
Failed Back Surgery Syndrome | 1 | 2017 | 22 | 0.150 |
Why?
|
State Government | 1 | 2020 | 372 | 0.150 |
Why?
|
Radiosurgery | 2 | 2017 | 1331 | 0.150 |
Why?
|
Medicare Part D | 1 | 2021 | 328 | 0.150 |
Why?
|
Temporal Bone | 2 | 2018 | 661 | 0.140 |
Why?
|
Nasal Polyps | 1 | 2022 | 360 | 0.140 |
Why?
|
Access to Information | 1 | 2020 | 320 | 0.140 |
Why?
|
Radiation Tolerance | 1 | 2019 | 486 | 0.140 |
Why?
|
Tongue | 1 | 2020 | 404 | 0.140 |
Why?
|
Laryngeal Diseases | 1 | 2020 | 241 | 0.140 |
Why?
|
Nose | 1 | 2020 | 509 | 0.140 |
Why?
|
Cohort Studies | 6 | 2019 | 40545 | 0.140 |
Why?
|
Cost Savings | 2 | 2021 | 925 | 0.140 |
Why?
|
Cough | 1 | 2020 | 555 | 0.140 |
Why?
|
Quality-Adjusted Life Years | 1 | 2022 | 1683 | 0.140 |
Why?
|
Complex Regional Pain Syndromes | 1 | 2017 | 124 | 0.130 |
Why?
|
Necrosis | 2 | 2017 | 1642 | 0.130 |
Why?
|
Postoperative Complications | 5 | 2018 | 15281 | 0.130 |
Why?
|
Neovascularization, Pathologic | 2 | 2017 | 2638 | 0.130 |
Why?
|
Laryngoscopy | 2 | 2020 | 710 | 0.130 |
Why?
|
Spondylolisthesis | 1 | 2017 | 163 | 0.130 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2020 | 8430 | 0.130 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2017 | 282 | 0.130 |
Why?
|
Vocal Cords | 1 | 2020 | 528 | 0.130 |
Why?
|
Tomography, X-Ray Computed | 2 | 2018 | 20121 | 0.120 |
Why?
|
Surgical Flaps | 1 | 2023 | 1629 | 0.120 |
Why?
|
Prescription Drugs | 1 | 2021 | 593 | 0.120 |
Why?
|
Radiography | 2 | 2015 | 7010 | 0.120 |
Why?
|
Rhinitis | 1 | 2022 | 690 | 0.120 |
Why?
|
Vocal Cord Paralysis | 1 | 2018 | 267 | 0.120 |
Why?
|
Reimbursement Mechanisms | 1 | 2020 | 670 | 0.120 |
Why?
|
Cranial Irradiation | 1 | 2017 | 401 | 0.120 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2019 | 3547 | 0.120 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2019 | 1770 | 0.120 |
Why?
|
Outpatients | 1 | 2021 | 1488 | 0.120 |
Why?
|
Immunomodulation | 1 | 2017 | 541 | 0.120 |
Why?
|
Postoperative Care | 1 | 2020 | 1485 | 0.110 |
Why?
|
Bone Screws | 1 | 2017 | 520 | 0.110 |
Why?
|
Pandemics | 4 | 2020 | 8385 | 0.110 |
Why?
|
Polysomnography | 1 | 2020 | 1776 | 0.110 |
Why?
|
Transforming Growth Factor beta | 2 | 2020 | 2006 | 0.110 |
Why?
|
Patient Readmission | 2 | 2017 | 3117 | 0.110 |
Why?
|
Spinal Diseases | 1 | 2018 | 538 | 0.110 |
Why?
|
Neoplasms | 1 | 2022 | 21675 | 0.110 |
Why?
|
Papillomaviridae | 1 | 2019 | 1119 | 0.110 |
Why?
|
Apoptosis | 3 | 2019 | 9718 | 0.110 |
Why?
|
Sinusitis | 1 | 2022 | 921 | 0.110 |
Why?
|
Electrodes, Implanted | 1 | 2017 | 825 | 0.110 |
Why?
|
Fluoroscopy | 1 | 2017 | 924 | 0.110 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5319 | 0.110 |
Why?
|
Propensity Score | 1 | 2019 | 1781 | 0.110 |
Why?
|
Cardiology | 1 | 2023 | 1668 | 0.100 |
Why?
|
Information Dissemination | 1 | 2020 | 1099 | 0.100 |
Why?
|
Adult | 13 | 2022 | 213889 | 0.100 |
Why?
|
Linear Models | 2 | 2019 | 5952 | 0.100 |
Why?
|
Hyperglycemia | 1 | 2020 | 1373 | 0.100 |
Why?
|
Prosthesis Failure | 1 | 2017 | 1203 | 0.100 |
Why?
|
Pain Measurement | 2 | 2018 | 3420 | 0.100 |
Why?
|
Facial Nerve | 2 | 2023 | 271 | 0.090 |
Why?
|
Cell Line, Tumor | 4 | 2020 | 16674 | 0.090 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2014 | 499 | 0.090 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2017 | 1503 | 0.090 |
Why?
|
Trauma Centers | 1 | 2016 | 891 | 0.090 |
Why?
|
Reoperation | 2 | 2017 | 4200 | 0.090 |
Why?
|
Hospitalists | 1 | 2014 | 304 | 0.090 |
Why?
|
Medical Staff, Hospital | 1 | 2014 | 601 | 0.090 |
Why?
|
Hospitals, Pediatric | 2 | 2016 | 1775 | 0.090 |
Why?
|
Spinal Cord Injuries | 1 | 2017 | 931 | 0.090 |
Why?
|
Body Height | 1 | 2015 | 1579 | 0.080 |
Why?
|
Disease Progression | 2 | 2015 | 13273 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2944 | 0.080 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6895 | 0.080 |
Why?
|
Antigens, Neoplasm | 1 | 2016 | 1988 | 0.080 |
Why?
|
Spine | 1 | 2015 | 1144 | 0.080 |
Why?
|
Diabetes Complications | 1 | 2015 | 1360 | 0.080 |
Why?
|
Medical Errors | 1 | 2017 | 1297 | 0.080 |
Why?
|
Cardiac Surgical Procedures | 1 | 2023 | 3537 | 0.080 |
Why?
|
Patient Admission | 1 | 2016 | 1380 | 0.080 |
Why?
|
Patient Discharge | 2 | 2017 | 3317 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2019 | 4422 | 0.080 |
Why?
|
Prognosis | 2 | 2019 | 29052 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8637 | 0.070 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39001 | 0.070 |
Why?
|
Orthopedic Procedures | 1 | 2017 | 1287 | 0.070 |
Why?
|
Length of Stay | 2 | 2017 | 6311 | 0.070 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 3655 | 0.070 |
Why?
|
Survival Analysis | 1 | 2019 | 10251 | 0.070 |
Why?
|
Cell Proliferation | 2 | 2019 | 10477 | 0.070 |
Why?
|
Cadaver | 2 | 2020 | 1335 | 0.070 |
Why?
|
Comorbidity | 2 | 2020 | 10380 | 0.070 |
Why?
|
Brain Neoplasms | 2 | 2017 | 8856 | 0.070 |
Why?
|
Patient Satisfaction | 1 | 2017 | 3391 | 0.060 |
Why?
|
Endothelium, Vascular | 1 | 2017 | 4459 | 0.060 |
Why?
|
Insurance Coverage | 1 | 2016 | 1900 | 0.060 |
Why?
|
Drug Synergism | 2 | 2019 | 1794 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15067 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2401 | 0.060 |
Why?
|
Mice | 6 | 2020 | 81154 | 0.060 |
Why?
|
Smiling | 1 | 2023 | 72 | 0.060 |
Why?
|
Smoking | 1 | 2019 | 8984 | 0.050 |
Why?
|
Denervation | 1 | 2023 | 278 | 0.050 |
Why?
|
Middle Ear Ventilation | 1 | 2022 | 94 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2014 | 3530 | 0.050 |
Why?
|
DNA | 1 | 2015 | 7295 | 0.050 |
Why?
|
Inflammation | 1 | 2020 | 10629 | 0.050 |
Why?
|
Emergency Service, Hospital | 2 | 2017 | 7658 | 0.050 |
Why?
|
Stroboscopy | 1 | 2020 | 64 | 0.050 |
Why?
|
Risk Assessment | 2 | 2019 | 23327 | 0.050 |
Why?
|
Prospective Studies | 2 | 2022 | 53250 | 0.050 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2023 | 493 | 0.050 |
Why?
|
Brain | 2 | 2017 | 26345 | 0.040 |
Why?
|
Disease Models, Animal | 4 | 2020 | 18027 | 0.040 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2020 | 294 | 0.040 |
Why?
|
Ohio | 1 | 2020 | 337 | 0.040 |
Why?
|
Smell | 1 | 2021 | 244 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11524 | 0.040 |
Why?
|
Animals | 6 | 2020 | 168660 | 0.040 |
Why?
|
Time Factors | 1 | 2019 | 40038 | 0.040 |
Why?
|
Head | 1 | 2023 | 878 | 0.040 |
Why?
|
Karnofsky Performance Status | 1 | 2017 | 173 | 0.040 |
Why?
|
Perception | 1 | 2023 | 1198 | 0.040 |
Why?
|
Risk Factors | 3 | 2020 | 72252 | 0.040 |
Why?
|
Otologic Surgical Procedures | 1 | 2018 | 145 | 0.040 |
Why?
|
Drugs, Generic | 1 | 2021 | 421 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2019 | 729 | 0.040 |
Why?
|
Health Facilities | 1 | 2021 | 572 | 0.030 |
Why?
|
Genes, erbB-2 | 1 | 2016 | 162 | 0.030 |
Why?
|
Pregnancy | 1 | 2018 | 29140 | 0.030 |
Why?
|
District of Columbia | 1 | 2016 | 157 | 0.030 |
Why?
|
Particle Size | 1 | 2020 | 1639 | 0.030 |
Why?
|
Chronic Disease | 2 | 2022 | 9139 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2020 | 21824 | 0.030 |
Why?
|
Chick Embryo | 1 | 2017 | 983 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2018 | 12243 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2019 | 1283 | 0.030 |
Why?
|
Osteotomy | 1 | 2018 | 820 | 0.030 |
Why?
|
Postoperative Period | 1 | 2017 | 1841 | 0.030 |
Why?
|
Logistic Models | 2 | 2018 | 13404 | 0.030 |
Why?
|
Gene Amplification | 1 | 2016 | 1063 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1479 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2015 | 57744 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2017 | 19232 | 0.020 |
Why?
|
Antigens, CD | 1 | 2020 | 4026 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2022 | 2837 | 0.020 |
Why?
|
Massachusetts | 1 | 2022 | 8660 | 0.020 |
Why?
|
Health Expenditures | 1 | 2022 | 2348 | 0.020 |
Why?
|
Spinal Cord | 1 | 2017 | 1809 | 0.020 |
Why?
|
Particulate Matter | 1 | 2020 | 2529 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 35409 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2015 | 3144 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2015 | 1828 | 0.020 |
Why?
|
Anxiety | 1 | 2022 | 4288 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6457 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 4183 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2039 | 0.020 |
Why?
|
Macrophages | 1 | 2020 | 5651 | 0.020 |
Why?
|
Child | 3 | 2022 | 77637 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2020 | 14563 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2016 | 25609 | 0.020 |
Why?
|
Cell Movement | 1 | 2017 | 5216 | 0.020 |
Why?
|
Infant | 2 | 2016 | 35122 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15211 | 0.010 |
Why?
|
Child, Preschool | 2 | 2016 | 40964 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12354 | 0.010 |
Why?
|
Depression | 1 | 2022 | 7760 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11360 | 0.010 |
Why?
|
Boston | 1 | 2014 | 9310 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15526 | 0.010 |
Why?
|
Young Adult | 2 | 2017 | 56392 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 12066 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6363 | 0.010 |
Why?
|
Melanoma | 1 | 2016 | 5508 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5230 | 0.010 |
Why?
|
Adolescent | 2 | 2016 | 85729 | 0.010 |
Why?
|
Hospitalization | 1 | 2014 | 10259 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23398 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2016 | 13112 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2016 | 20827 | 0.010 |
Why?
|